Why the study?
Does culprit-lesion-only PCI reduce the risk of death or renal-replacement therapy compared to immediate multivessel PCI in patients with acute myocardial infarction and cardiogenic shock?
Population
Patients with acute myocardial infarction and cardiogenic shock
Comparison
Culprit-lesion-only percutaneous coronary… vs Immediate multivessel percutaneous coronary…
Design
RCT
Follow-up
1 year
Authors
Loading...
Supports culprit-lesion-only PCI in AMI with cardiogenic shock; challenges prior consensus favoring multivessel PCI.
Does culprit-lesion-only PCI reduce the risk of death or renal-replacement therapy compared to immediate multivessel PCI in patients with acute myocardial infarction and cardiogenic shock?
In patients with AMI and cardiogenic shock, culprit-lesion-only PCI reduces the 30-day risk of death or renal replacement therapy compared to immediate multivessel PCI, though 1-year mortality does not differ significantly.
Thiele et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: